Smith ER et al. observed that urinary NGAL levels and a uNGAL/creatinine ratio were associated with higher risk of death and initiation of extrarenal replacement therapy independent of renal and cardiovascular risk factors in 158 adult patients with stage 3 or 4 chronic kidney disease [50]. The gene discussed is LCN2; the disease is chronic kidney disease.